Wall Street Analysts Believe Phathom Pharmaceuticals (PHAT) Could Rally 107.4%: Here's is How to Trade

Shares of Phathom Pharmaceuticals, Inc. (PHAT) have gained 184.1% over the past four weeks to close the last trading session at $8.92, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$18.50 indicates a potential upside of 107.4%.The mean estimate comprises eight short-term price targets with a standard deviation of $8.09. While the lowest estimate of$5 indicates a 44% decline f ...